Transcript Document

Update on WHO GAVI European
Regional Working Group and hepatitis
B Immunization
Viral Hepatitis
Prevention Board
Meeting
7-8 November 2002
Catania, Italy
WHO Regional Office for Europe
100
%
Reported immunization coverage rate
WHO/EURO, 1990-2001
80
60
40
20
BCG
WHO Regional Office for Europe
Years
OPV3/DTP3
MCV
01
20
00
20
99
98
97
96
95
94
93
92
91
90
0
HepB3
1991 Coverage for DTP3/OPV3 vaccine
at 12 months of age
Administrative data: 1991 Cisid
>95%
90-95%
>80 %
80-90%
<80%
no data reported
WHO Regional Office for Europe
2001 Coverage for DTP3/OPV-IPV3 vaccine
at 12 months of age
Administrative data: 2001 Joint Reporting Form
>95%
90-95%
80-90%
<80%
no data reported
WHO Regional Office for Europe
Introduction of new/underutilized vaccines
• Substantial progress in introducing HepB
• 41 countries already included into routine
immunization programme
– 37 infant & routine
– 4 adolescent
• Hib; widely used in W. Europe, limited in other
areas
– Need for burden assessment
• Improvement in implementation
WHO Regional Office for Europe
Hep B immunization programmes,
WHO European Region, 2002
Routine infant
Routine newborn
Adolescent only
Selective HepB immun..
WHO Regional Office for Europe
Al
ba
Ar ni a
m
en
Au i a
s
Bu tria
lg
a
Be ria
la
G rus
eo
rg
i
Ky Is a
rg rae
Ka yzs l
za ta
kh n
Li sta
th n
ua
ni
La a
M tvia
ol
do
v
Po a
l
Po and
rtu
g
R al
u
Sl ssi a
ov
a
Tu kia
rk
U ey
U kra
zb i n
ek e
is
ta
n
Reported DTP3 and HepB3 coverage
WHO/EURO, 2001
100
90
80
70
60
50
40
30
20
10
0
DTP3
WHO Regional Office for Europe
HepB3
Data from JRF
Objectives of GAVI
Immunization is the right of every child to be
protected against VPDs
• Improve access to sustainable immunization
services
• Expand use of all existing vaccines
• Accelerate research and development of vaccines,
with special focus to developing country needs
• Immunization an integral part of health systems
and international development
WHO Regional Office for Europe
GAVI Vaccine Fund support
* new and under-used vaccines
– Hep B
– Hib
– Yellow fever; bundled with safety equipment
* immunization services support
* injection safety support
WHO Regional Office for Europe
What will the FUND finance ?
DTP3
coverage
<50%
Immunization
services and
injection safety
Basic Conditions
GNP/capita < US$ 1000
ICC or equivalent
Immunization assessment
in last 3 years
Multi-year plan for
Immunization
Injection safety strategy
WHO Regional Office for Europe
DTP3
coverage
50% - 80%
Immunization
services, new and
under-used
vaccines and
injection safety
DTP3
coverage
>80%
New and underused vaccines and
injection safety
Countries eligible for support from the
GAVI Vaccine Fund
Eleven out of 51 countries:
•
•
•
•
•
•
Albania
Armenia
Azerbaijan
Bosnia & Herzegovina
Georgia
Kyrgyzstan
WHO Regional Office for Europe
•
•
•
•
•
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Status of country applications for
GAVI / VF support, October 2002
Status of country applications
Countries
SIS
Albania
Hep B
Hib
Inject.Safety
Inject.Safety
Assessment
Approved
Conditional
re-submit
2000
Not yet
Approved
2003
Armenia
Approved
Approved
Azerbaijan
Approved
Approved
Conditional
2003
Approved
re-submit
Postponed
Approved
Approved
Oct-02
Bosnia &
Herzegovina
Georgia
Approved
Kyrgyzstan
Approved
Approved
Conditional
2001
Moldova
Approved
Not yet
re-submit
2000
Approved
re-submit
2002
Turkmenistan
Approved
re-submit
2003
Ukraine
Approved
Not yet
Sep-02
Uzbekistan
Approved
Approved
2001
Tajikistan
WHO Regional Office for Europe
Approved
Not yet
Status of HepB introduction in
GAVI / VF eligible countries (# 1)
Country 1st GAVI supply
Status of HepB introduction
ALB
October 2001
Continued; started in 1994
ARM
June 2001
Continued; started in 1999
AZE
June 2001
Started in October 2001
BiH
Not yet
Started in 1999
GEO
August 2002
Started in 2000 (USAID)
KGZ
March 2001
Started in 1999; since May
2001 in whole country
WHO Regional Office for Europe
Status of HepB introduction in
GAVI / VF eligible countries (# 2)
Country 1st GAVI supply
Status of HepB introduction
MDA
June 2002
Started in 1995 (JICA)
TJK
December 2001
Started in February 2002
TKM
November 2001
Started in January 2002
UKR
Not yet
Started in 1996
UZB
August 2001
Started in October 2001
WHO Regional Office for Europe
GAVI related activities
WHO/EURO
• Immunization and cold chain reviews
• Disease burden assessments
• Planning
– Multi-year national immunization plans including new
vaccine introduction
– Safety of immunization
– Financial sustainability
• Implementation
– Training at national and subnational levels
– Supervision
• Coordination
– National ICCs
WHO Regional Office for Europe
GAVI related activities
WHO/EURO
Monitor progress
– Annual progress reports and joint reporting from
– Data quality audits
• Subregional immunization programme
managers meetings
• St Petersburg 2001
• Vienna 2002
• Kyiv 2003 (planned)
• Expansion to other countries
– policies and strategies
– training programmes and material
– support for vaccine procurement
WHO Regional Office for Europe
Technical support to GAVI countries, 2000-2002
Areas of technical support
Countries
ALB
ARM
AZE
BIH
GEO
KGZ
MDA
TJK
TKM
UKR
UZB
GAVI
documents
National plans
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
WHO Regional Office for Europe
MLM+HepB
training
x
x
x
x
x
Injection
safety
assessment
Cold chain
assesment
Immunization
safety planning
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
European GAVI Regional Working
Group
• Established and regularly met since 2001
• Members: WHO, UNICEF, World Bank,
CVP/PATH, Vaccine Fund, VHPB and
CDC/Atlanta
• Coordinate GAVI partners’ support and activities
• Ensure timely and appropriate technical and financial
support to countries
• Identify needs for strengthening immunization services
and capacities for introduction of new vaccines
• Strengthen National ICCs
• Provide input to the Regional ICC
WHO Regional Office for Europe
GAVI initiative and lessons learned
WHO European Region
• Opportunity for accelerating new vaccine
introduction
• Impact on strengthening immunization services
–
–
–
–
programme assessments
multi-year immunization plans
resource mobilization, coordination (national ICCs)
emphasis on injection safety
• Expand infrastructure, build capacity
– Access (80/80 district goal)
• Apply lessons learned to other countries
WHO Regional Office for Europe
Areas for future action
• Strengthen immunization service delivery
• Provide policy guidelines
• Use national multi-year plans as a managerial tool
• Monitor implementation/exchange information
• Support mid-term reviews and development of FSP
• Technical support for Hib burden assessments
• Support training, also for introduction of new vaccines
• Apply lessons learned/experience gained to “non-GAVI”
countries
WHO Regional Office for Europe